Clinical Trials Directory

Trials / Completed

CompletedNCT06298617

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis: A Comparative Study Versus Exploratory Laparoscopy

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Benha University · Academic / Other
Sex
Female
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Endometriosis (EMs) is one of the commonest chronic inflammatory disorder affecting women and is characterized by the presence and growth of endometrial-like glandular epithelial and stromal cells outside the uterus leading to multiple clinical symptoms affecting patients quality of life and fertility with high recurrence rate . The systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) are documented as prognostic serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies for various cancers .

Conditions

Interventions

TypeNameDescription
PROCEDUREDiagnostic laparoscopyAll women will undergo exploratory laparoscopy under general anesthesia
DIAGNOSTIC_TESTFull Blood Count (FBC)Blood samples withdrawn from patients on EDITA tubes and gone through full blood count and differential leucocytic count

Timeline

Start date
2023-01-01
Primary completion
2023-07-30
Completion
2023-12-25
First posted
2024-03-07
Last updated
2024-03-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06298617. Inclusion in this directory is not an endorsement.